Major flares in women with SLE on combined oral contraception.
Two recent trials concluded that the use of oral contraceptives (OC) did not induce flares in lupus patients. We record our experience with OC in patients with stable lupus. Eight patients were enrolled in an open trial. Six received a combined contraceptive pill and two were allocated to the control arm. During a 12 month follow-up, 3 patients in the active arm experienced 4 major flares. One patient died as a result of uncontrolled disease complicated by sepsis. At this point, we abandoned the trial. The 2 patients in the control arm experienced no disease exacerbation during the 7 months of observation. We would urge that patients who are placed on OC be closely monitored.
Whitelaw
D A
DA
Division of Rheumatology, Tygerberg Hospital, P.O. Box 19063, 7505, Tygerberg, Western Cape, South Africa. dwhit@sun.ac.za.
Jessop
S J
SJ
Division of Dermatology, Groote Schuur Hospital, Cape Town, South Africa.
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D019584:Hot Flashes / Q000139:chemically induced*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors
D003276:Contraceptives, Oral